Re-examining a strong recommendation based on low-quality evidence in acute chest syndrome.

Pediatr Blood Cancer

Children's Hospital and the Division of Pediatric Hematology-Oncology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

Published: May 2023

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.30266DOI Listing

Publication Analysis

Top Keywords

re-examining strong
4
strong recommendation
4
recommendation based
4
based low-quality
4
low-quality evidence
4
evidence acute
4
acute chest
4
chest syndrome
4
re-examining
1
recommendation
1

Similar Publications

Objective/background: Using meta-analytic structural equation modeling (MASEM), we examined the link between Big Five personality traits and subjective well-being (SWB), operationalized as three separate components and as a latent factor indicated by life satisfaction (LS), positive affect (PA), and negative affect (NA). PA and NA were assessed based on frequency of a broad range of affective experiences, rather than intensity of high arousal affective experiences, thus excluding studies using the Positive and Negative Affect Schedule.

Method: 35 samples were included, encompassing 22,135 participants from 14 countries, in which all eight variables were assessed.

View Article and Find Full Text PDF

Artificial Intelligence and Blockchain: How Should Emerging Technologies Be Governed?

Front Res Metr Anal

February 2022

Korea Policy Center for the Fourth Industrial Revolution (KPC4IR), Korea Advanced Institute of Science and Technology, Daejeon, South Korea.

Governing emerging technologies is one of the most important issues of the twenty-first century, and primarily concerns the public, private, and social initiatives that can shape the adoption and responsible development of digital technologies. This study surveys the emerging landscape of blockchain and artificial intelligence (AI) governance and maps the ecosystem of emerging platforms within industry and public and civil society. We identify the major players in the public, private, and civil society organizations and their underlying motivations, and examine the divergence and convergence of these motivation and the way they are likely to shape the future governance of these emerging technologies.

View Article and Find Full Text PDF

Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells.

Pharmaceuticals (Basel)

November 2021

Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.

Crizotinib was a first generation of ALK tyrosine kinase inhibitor approved for the treatment of -positive non-small-cell lung carcinoma (NSCLC) patients. COMPARE and cluster analyses of transcriptomic data of the NCI cell line panel indicated that genes with different cellular functions regulated the sensitivity or resistance of cancer cells to crizotinib. Transcription factor binding motif analyses in gene promoters divulged two transcription factors possibly regulating the expression of these genes, i.

View Article and Find Full Text PDF

More and more well-documented failure of established companies which could not respond to rapid market changes, such as Kodak and Nokia, demonstrate the importance of transferring marketing information into real firm performance. While marketing strategy and management literature has long advocated the direct impact of strong firm market orientation (MO) on new product development (NPD) performance, limited research has discussed the mediating mechanism of this MO-NPD performance relationship. Using the traditional source-position-performance (SPP) framework, this study focuses on the innovation ambidexterity perspective to investigate the mediating mechanism between MO and NPD performance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!